← Leaderboards
Michael Andrew Fischbach
University Of California, San Francisco
$20,742,968
Attributed
$31,089,229
Total exposure
10
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,089,229 · 10
By mechanism
R01$20,949,645 · 6
DP1$5,505,500 · 1
DP2$2,317,500 · 1
P01$1,897,359 · 1
R21$419,225 · 1
Top collaborators
- Timothy W Meyer10 shared
- Justin Sonnenburg10 shared
- Katherine Paige Lemon9 shared
- Michael S. Diamond5 shared
- Tatyana V. Golovkina5 shared
- Scott A. Handley5 shared
- Thaddeus S Stappenbeck5 shared
- Anita Sil2 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Anita Sil$24,389,913
Others in their field
Top investigators on “Microbiome”
- James E. Gern · University Of Wisconsin-Madison$135,210,239
- Jeffrey P Krischer · University Of South Florida$110,106,410
- Richard A Gibbs · Baylor College Of Medicine$97,085,750
- Mine Cicek · Mayo Clinic Rochester$80,808,856
- Richard K. Wilson · Washington University$72,151,126
- Stephen Norman Thibodeau · Mayo Clinic Rochester$70,215,522
Research focus
MicrobiomeMicrobiotaGeneticGut MicrobiotaGenesMicrobeBacteriaMicrobialCommunitiesMutantAntibioticsProductionHuman MicrobiomePhenotypePreventMetagenomicsMolecularLinkBaseResponseGerm-FreeMetabolomicsMetabolicInfection
Grant awards (49)
Building the foundations of commensal vaccines$730,870
R01 · FY2025 · AI · contact PI
Gut Microbiota Modulation of Chikungunya Virus Infection and Pathogenesis$652,163
R01 · FY2025 · AI
Building the foundations of commensal vaccines$751,181
R01 · FY2024 · AI · contact PI
Gut Microbiota Modulation of Chikungunya Virus Infection and Pathogenesis$657,820
R01 · FY2024 · AI
Dietary and Microbial Reprogramming of Intestinal Microbiota-Produced Metabolites$591,098
R01 · FY2024 · DK
Building the foundations of commensal vaccines$770,910
R01 · FY2023 · AI · contact PI
Gut Microbiota Modulation of Chikungunya Virus Infection and Pathogenesis$661,548
R01 · FY2023 · AI
Dietary and Microbial Reprogramming of Intestinal Microbiota-Produced Metabolites$625,691
R01 · FY2023 · DK
Project 3: Microbiota generated aryl sulfates and secondary bile acids in cardiometabolic disease$475,392
P01 · FY2023 · HL · contact PI
Virally-induced tumorigenesis controlled by the microbiota$467,351
R01 · FY2023 · CA
Building the foundations of commensal vaccines$794,261
R01 · FY2022 · AI · contact PI
Dietary and Microbial Reprogramming of Intestinal Microbiota-Produced Metabolites$635,777
R01 · FY2022 · DK
Gut Microbiota Modulation of Chikungunya Virus Infection and Pathogenesis$620,348
R01 · FY2022 · AI
Project 3: Microbiota generated aryl sulfates and secondary bile acids in cardiometabolic disease$473,989
P01 · FY2022 · HL · contact PI
Virally-induced tumorigenesis controlled by the microbiota$467,351
R01 · FY2022 · CA
Dietary and Microbial Reprogramming of Intestinal Microbiota-Produced Metabolites$644,301
R01 · FY2021 · DK
Gut Microbiota Modulation of Chikungunya Virus Infection and Pathogenesis$624,846
R01 · FY2021 · AI
Antibiotics from nose and throat commensals that impact pathogen colonization$484,679
R01 · FY2021 · AI
Virally-induced tumorigenesis controlled by the microbiota$476,888
R01 · FY2021 · CA
Project 3: Microbiota generated aryl sulfates and secondary bile acids in cardiometabolic disease$473,989
P01 · FY2021 · HL · contact PI
A complete map of the top 100 molecules from the gut microbiome$1,099,000
DP1 · FY2020 · DK · contact PI
Dietary and Microbial Reprogramming of Intestinal Microbiota-Produced Metabolites$690,557
R01 · FY2020 · DK
Antibiotics from nose and throat commensals that impact pathogen colonization$497,393
R01 · FY2020 · AI
Virally-induced tumorigenesis controlled by the microbiota$476,888
R01 · FY2020 · CA
Project 3: Microbiota generated aryl sulfates and secondary bile acids in cardiometabolic disease$473,989
P01 · FY2020 · HL · contact PI
A complete map of the top 100 molecules from the gut microbiome$1,099,000
DP1 · FY2019 · DK · contact PI
Antibiotics from nose and throat commensals that impact pathogen colonization$532,744
R01 · FY2019 · AI
Virally-induced tumorigenesis controlled by the microbiota$492,388
R01 · FY2019 · CA
Identification and characterization of natural products from the human microbiota$353,250
R01 · FY2019 · DK · contact PI
A complete map of the top 100 molecules from the gut microbiome$1,099,000
DP1 · FY2018 · DK · contact PI
Dietary and Microbial Reprogramming of Intestinal Microbiota-Produced Metabolites$634,157
R01 · FY2018 · DK
Antibiotics from nose and throat commensals that impact pathogen colonization$531,603
R01 · FY2018 · AI
Identification and characterization of natural products from the human microbiota$353,250
R01 · FY2018 · DK · contact PI
A complete map of the top 100 molecules from the gut microbiome$1,099,000
DP1 · FY2017 · DK · contact PI
Dietary and Microbial Reprogramming of Intestinal Microbiota-Produced Metabolites$650,808
R01 · FY2017 · DK
Antibiotics from nose and throat commensals that impact pathogen colonization$542,086
R01 · FY2017 · AI
Identification and characterization of natural products from the human microbiota$353,250
R01 · FY2017 · DK · contact PI
A complete map of the top 100 molecules from the gut microbiome$1,109,500
DP1 · FY2016 · DK · contact PI
Dietary and Microbial Reprogramming of Intestinal Microbiota-Produced Metabolites$662,793
R01 · FY2016 · DK
Identification and characterization of natural products from the human microbiota$356,625
R01 · FY2016 · DK · contact PI
Dietary and Microbial Reprogramming of Intestinal Microbiota-Produced Metabolites$673,919
R01 · FY2015 · DK
Antibiotics from nose and throat commensals that impact pathogen colonization$442,757
R01 · FY2015 · AI
Dietary and Microbial Reprogramming of Intestinal Microbiota-Produced Metabolites$727,558
R01 · FY2014 · DK
Antibiotics from nose and throat commensals that impact pathogen colonization$442,247
R01 · FY2014 · AI
Antibiotics from nose and throat commensals that impact pathogen colonization$414,710
R01 · FY2013 · AI
Natural products from a human-asssociated fungal pathogen$184,475
R21 · FY2013 · AI
Antibiotics from nose and throat commensals that impact pathogen colonization$463,579
R01 · FY2012 · AI
Natural products from a human-asssociated fungal pathogen$234,750
R21 · FY2012 · AI
Identifying and characterizing small molecules from the human microbiome$2,317,500
DP2 · FY2010 · OD · contact PI